*Available in 2026, currently undergoing FDA approval

Revolutionizing Type 1 Diabetes Diagnosis

We are developing an accessible, cost-efficient, and accurate diagnostic tool for Type 1 Diabetes.

*Available in 2026, currently undergoing FDA approval process.

Selected as a finalist for the 
2024 Innovation Challenge at the American Diabetes Association

Selected as a finalist for the 
2024 Innovation Challenge at the American Diabetes Association

Problem

One-third of type 1 diabetes patients are misdiagnosed and not getting a proper treatment.

  • Adults get type 1 diabetes, too.

    Traditionally, it has been thought that type 1 diabetes only affects children. However, a recent study indicated that 50% of cases occur in adulthood.

    Read the study

  • Misdiagnosis is a common issue.

    A recent study shows that 38% of type 1 diabetes patients are misdiagnosed as type 2 diabetes.

    Read the study

  • There’s no definitive tool to distinguish the type of diabetes.

    Though autoantibody tests (e.g., GAD) are available, the accuracy of these tests is limited, and their accessibility is also low.

    Read the study

Solution

Our at-home DNA test would change the situation - it would be an accessible, cost-efficient, and accurate tool to support the right diagnosis.

  • 1

    Accessible

    • Order online, at-home DNA test
    • Non-invasive, saliva base DNA test
  • 2

    Cost efficient

    • Low cost compared to other blood-based autoantibody tests
    • No repetitive test - take once, and that’s all
  • 3

    Accurate

    • Show better accuracy (sensitivity and specificity) compared to the autoantibody tests
    • It aims to get FDA approval in 2026, which proves and validates the test accuracy

How It Works

Our Roadmap

Vision and Goal

As T1D Strong, we are solving problems around individuals with Type 1 Diabetes

Stay in touch with the T1D Strong website - we’ll keep you updated.

Powered by Genomelink

Collaborative project between
T1D Strong and Genomelink